Amphastar Pharmaceuticals (AMPH) Cash from Operations (2013 - 2026)

Amphastar Pharmaceuticals' Cash from Operations history runs 14 years deep, the most recent figure standing at 47840000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 36.39% year-over-year to 47840000.0; the TTM figure through Mar 2026 stood at 168878000.0 (down 12.58% YoY), while the FY2025 annual figure was 156115000.0, down 26.84% from the prior year.
• Cash from Operations was 47840000.0 for Q1 2026 at Amphastar Pharmaceuticals, up from 32863000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 69109000.0 in Q2 2024 to a low of 2815000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 40589705.88 across 5 years, with a median of 40382000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations tumbled 91.25% in 2022, then soared 1851.08% in 2023.
• A 5-year view of Cash from Operations shows it stood at 15226000.0 in 2022, then jumped by 56.73% to 23864000.0 in 2023, then gained by 21.62% to 29024000.0 in 2024, then advanced by 13.23% to 32863000.0 in 2025, then soared by 45.57% to 47840000.0 in 2026.
• The last three Cash from Operations figures came in at 47840000.0 (Q1 2026), 32863000.0 (Q4 2025), and 52583000.0 (Q3 2025), per Business Quant data.